Read more

August 09, 2021
1 min read
Save

Both TSA, RTSA are viable options for low-demand patients aged 75 years or older

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Reverse total shoulder arthroplasty is an acceptable option for low-demand patients aged 75 years or older; however, yielded the highest percentage of patients who achieved substantial clinical benefit.

Perspective from Jonathan C. Levy, MD

In a recently published study, Sarav S. Shah, MD, and colleagues compared outcomes of 659 patients who underwent TSA and 172 patients who underwent reverse (RTSA) from 2007 to 2016. esearchers stratified each patient into three cohorts based on age: younger 65 to 74 years and 75 years or older.

Shah graphic
Additionally, 90.5% of patients who underwent TSA and 76.9% of patients who underwent RTSA achieved substantial clinical benefit (SCB). Data were derived from Shah SS, et al. Orthopedics. 2021;doi:10.3928/01477447-20210618-24.

Outcome measures included American Shoulder and Elbow Surgeons (ASES) scores, houlder ctivity cale (SAS) scores andSF-12 hysical omponent core (PCS) and ental omponent core (MCS).

According to the study, TSA yielded the greatest improvements in 2-year ASES and SAS scores across all three age groups, yet RTSA remained a “viable option,” Shah and colleagues wrote in the study. In patients aged 75 years or older, 93.1% of patients who underwent TSA and 92.3% of patients who underwent RTSA achieved minimal clinically important difference, while 90.5% of patients who underwent TSA and 76.9% of patients who underwent RTSA achieved substantial clinical benefit (SCB).

“The results support a trend that primary RTSA is a viable option for low-demand patients aged 75 years or older; however, appropriately indicated TSA offers a potential for greater improvement in ASES scores and is more successful at achieving SCB compared with RTSA at 2-year follow-up,” Shah and colleagues added. “This study highlights the importance of indications and a shared decision-making model to ensure patient satisfaction,” they wrote.